rs1057519922
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA
|
|
0.800 |
GeneticVariation |
UNIPROT |
Activating de novo mutations in NFE2L2 encoding NRF2 cause a multisystem disorder.
|
29018201 |
2017 |
rs1553487942
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA
|
|
0.800 |
GeneticVariation |
UNIPROT |
Activating de novo mutations in NFE2L2 encoding NRF2 cause a multisystem disorder.
|
29018201 |
2017 |
rs1553487947
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA
|
|
0.800 |
GeneticVariation |
UNIPROT |
Activating de novo mutations in NFE2L2 encoding NRF2 cause a multisystem disorder.
|
29018201 |
2017 |
rs1553488015
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA
|
|
0.800 |
GeneticVariation |
UNIPROT |
Activating de novo mutations in NFE2L2 encoding NRF2 cause a multisystem disorder.
|
29018201 |
2017 |
rs1057519922
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA
|
T |
0.800 |
CausalMutation |
CLINVAR |
|
|
|
rs1553487942
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA
|
T |
0.800 |
CausalMutation |
CLINVAR |
|
|
|
rs1553487947
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA
|
T |
0.800 |
CausalMutation |
CLINVAR |
|
|
|
rs1553488015
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA
|
T |
0.800 |
CausalMutation |
CLINVAR |
|
|
|
rs12471433
|
NFE2L2;MIR3128
|
Glomerular Filtration Rate
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Mapping eGFR loci to the renal transcriptome and phenome in the VA Million Veteran Program.
|
31451708 |
2019 |
rs17581525
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
Glomerular Filtration Rate
|
G |
0.700 |
GeneticVariation |
GWASCAT |
Sex-specific and pleiotropic effects underlying kidney function identified from GWAS meta-analysis.
|
31015462 |
2019 |
rs34468415
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
Glomerular Filtration Rate
|
A |
0.700 |
GeneticVariation |
GWASCAT |
A catalog of genetic loci associated with kidney function from analyses of a million individuals.
|
31152163 |
2019 |
rs35284526
|
NFE2L2;MIR3128
|
Glomerular Filtration Rate
|
A |
0.700 |
GeneticVariation |
GWASCAT |
A catalog of genetic loci associated with kidney function from analyses of a million individuals.
|
31152163 |
2019 |
rs35955110
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
Glomerular Filtration Rate
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Trans-ethnic kidney function association study reveals putative causal genes and effects on kidney-specific disease aetiologies.
|
30604766 |
2019 |
rs6433657
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
Glomerular Filtration Rate
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Mapping eGFR loci to the renal transcriptome and phenome in the VA Million Veteran Program.
|
31451708 |
2019 |
rs1057519920
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
Transitional cell carcinoma of bladder
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519920
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
Malignant Uterine Corpus Neoplasm
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519920
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
Uterine Cervical Neoplasm
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519920
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
Renal Cell Carcinoma
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519920
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
Squamous cell carcinoma of the head and neck
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519920
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
Squamous cell carcinoma of lung
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519920
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
Uterine Cervical Neoplasm
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519920
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
Malignant Uterine Corpus Neoplasm
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519920
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
Adenocarcinoma of lung (disorder)
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519920
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
Adenocarcinoma of lung (disorder)
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1057519920
|
Entrez Id: |
4780 |
Gene Symbol: |
NFE2L2 |
NFE2L2
|
Uterine Cervical Neoplasm
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |